SOCS3 and cancer: As one of the most key negative regulating factors of the JAK/STAT signaling pathway, SOCS3 downregulated cancer progression in lung and pancreatic cancers, which are similar to our analysis in vitro (He et al., 2003; Lesina et al., 2011).